Cargando…
Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis
This study aimed to investigate the short‐term efficacy and safety of tolvaptan as an add‐on to traditional diuretics in patients with acute heart failure (AHF). The PubMed, EMBASE, Cochrane Library, and Web of Science databases were comprehensively searched for all randomized controlled trials (RCT...
Autores principales: | Luo, Xiandu, Jin, Qi, Wu, Yanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272393/ https://www.ncbi.nlm.nih.gov/pubmed/32500625 http://dx.doi.org/10.1002/prp2.614 |
Ejemplares similares
-
Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials
por: Ma, Guang, et al.
Publicado: (2019) -
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis
por: Wang, Chunbin, et al.
Publicado: (2017) -
Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis
por: Wang, Lili, et al.
Publicado: (2019) -
Tolvaptan add-on therapy and its effects on efficacy parameters and outcomes in patients hospitalized with heart failure
por: Kansara, Tikal, et al.
Publicado: (2022) -
Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)